Screener
aTyr Pharma ATYR Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from aTyr Pharma’s reported figures.
The source filing: aTyr Pharma’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001339970-26-000053
FAQ
- What is aTyr Pharma's free cash flow?
- aTyr Pharma (ATYR) reported free cash flow of -$9.42M in Q2 2026.
- How has aTyr Pharma's free cash flow changed year-over-year?
- aTyr Pharma's free cash flow increased by 32.2% year-over-year, from -$13.9M to -$9.42M.
- What is the long-term trend for aTyr Pharma's free cash flow?
- Over 4 years (2021 to 2025), aTyr Pharma's free cash flow has grown at a 16.9% compound annual growth rate (CAGR), from -$33.27M to -$62.06M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about aTyr Pharma's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude